1. Home
  2. SLGL vs GOCO Comparison

SLGL vs GOCO Comparison

Compare SLGL & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • GOCO
  • Stock Information
  • Founded
  • SLGL 1997
  • GOCO 2001
  • Country
  • SLGL Israel
  • GOCO United States
  • Employees
  • SLGL N/A
  • GOCO N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • SLGL Health Care
  • GOCO Finance
  • Exchange
  • SLGL Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • SLGL 69.1M
  • GOCO 70.3M
  • IPO Year
  • SLGL 2018
  • GOCO 2020
  • Fundamental
  • Price
  • SLGL $37.00
  • GOCO $4.02
  • Analyst Decision
  • SLGL Strong Buy
  • GOCO Hold
  • Analyst Count
  • SLGL 1
  • GOCO 1
  • Target Price
  • SLGL $50.00
  • GOCO $12.00
  • AVG Volume (30 Days)
  • SLGL 16.8K
  • GOCO 38.4K
  • Earning Date
  • SLGL 11-14-2025
  • GOCO 11-06-2025
  • Dividend Yield
  • SLGL N/A
  • GOCO N/A
  • EPS Growth
  • SLGL N/A
  • GOCO N/A
  • EPS
  • SLGL N/A
  • GOCO N/A
  • Revenue
  • SLGL $23,931,000.00
  • GOCO $822,444,000.00
  • Revenue This Year
  • SLGL N/A
  • GOCO $2.06
  • Revenue Next Year
  • SLGL $31.17
  • GOCO $5.47
  • P/E Ratio
  • SLGL N/A
  • GOCO N/A
  • Revenue Growth
  • SLGL 264.86
  • GOCO 17.46
  • 52 Week Low
  • SLGL $4.01
  • GOCO $4.03
  • 52 Week High
  • SLGL $52.26
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 53.73
  • GOCO 31.08
  • Support Level
  • SLGL $38.01
  • GOCO $4.03
  • Resistance Level
  • SLGL $42.00
  • GOCO $4.54
  • Average True Range (ATR)
  • SLGL 3.42
  • GOCO 0.19
  • MACD
  • SLGL -0.95
  • GOCO -0.02
  • Stochastic Oscillator
  • SLGL 30.02
  • GOCO 5.81

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: